Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07209384) titled 'Clinical Efficacy of Transarterial Chemoembolization in Elderly Patients With Advanced Unresectable Colorectal Cancer' on Oct. 1.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Junpeng Wang

Condition: Unresectable Colorectal Cancer Advanced Malignancy Elderly (People Aged 65 or More)

Intervention: Procedure: Transarterial chemoembolization

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 1, 2025

Target Sample Size: 50

To know more, vi...